EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Caffeine Therapy for Apnea of Prematurity: Single-Center Study on Dosing Practices and Perceived Effectiveness

Kelly K Storm, Robert B Flint, Wes Onland, Anton H van Kaam, Irwin K M Reiss, G Jeroen Hutten, Sinno H P Simons

Neonatology · 2024

DOI: 10.1159/000543074 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neonatology, 2024. Verfasst von Kelly K Storm und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neonatal and Pediatric Intensive Care, Division of Neonatology, Erasmus University Medical Center - Sophia Children's Hospital, Rotterd…. Hauptthemen laut MEDLINE: Caffeine, Apnea, Infant, Premature, Diseases, Central Nervous System Stimulants. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Caffeine is the registered pharmacologic treatment for apnea of prematurity and is extensively used in the neonatal intensive care units (NICUs) based on evidence from randomized controlled trials. This study aimed to describe the clinical use of caffeine based on real-world data, hypothesizing a divergence from the registered dosing regimen.

Methods

A retrospective analysis included infants born before 30 weeks of gestation, admitted to the NICU of the Erasmus MC Rotterdam from 2018 to 2021. Exclusion criteria comprised infants admitted after postnatal day 2, those not receiving caffeine during admission, patients admitted for less than 24 h, those who spent less than 24 h on non-invasive support, and cases lacking medication data. The primary outcome was the proportion of patients receiving an average caffeine dose higher than registered on the label.

Results

A total of 451 patients with a median gestational age of 28+0 weeks (IQR 26+2–29+0) and birthweight of 1,015 g (IQR 800–1,218) were included. Of these, 402 infants (89%) received an average daily caffeine dosage exceeding the registered dose range. The median caffeine maintenance dose per patient was 5.3 mg/kg/day (IQR 5.0–5.8), with additional therapy (mini-load, doxapram, or intubation) needed in 318 patients (71%).

Conclusion

This study highlights the frequent use of higher caffeine dosages in clinical practice than registered and recommended based on long-term safety data. Despite these high dosages and frequent mini-loads, 28% of patients still required additional treatment with doxapram and/or invasive mechanical ventilation, indicating the need for individualized dosing strategies or alternative therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CaffeineApneaInfant, Premature, DiseasesCentral Nervous System StimulantsHumansInfant, NewbornRetrospective StudiesFemaleMaleIntensive Care Units, NeonatalGestational AgeInfant, PrematureTreatment OutcomeInfant, Extremely PrematureNetherlandsDose-Response Relationship, Drug

Stichwörter der Autor:innen

Apnea of prematurityCaffeineNeonatal intensive care unitPharmacotherapyPremature infants

Substanzen

CaffeineCentral Nervous System Stimulants

Autor:innen und Institutionen

  • Department of Neonatal and Pediatric Intensive Care, Division of Neonatology, Erasmus University Medical Center - Sophia Children's Hospital, Rotterdam, The Netherlands.
  • Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Department of Neonatology, Emma Children's Hospital, Amsterdam UMC, Amsterdam, The Netherlands.
  • Amsterdam Reproduction and Development Research Institute, Amsterdam, The Netherlands.

Zitieren

APA

Storm, K. K., Flint, R. B., Onland, W., van Kaam, A. H., Reiss, I. K. M., Hutten, G. J., & Simons, S. H. P. (2024). Caffeine Therapy for Apnea of Prematurity: Single-Center Study on Dosing Practices and Perceived Effectiveness. Neonatology. https://doi.org/10.1159/000543074

Vancouver

Storm KK, Flint RB, Onland W, van Kaam AH, Reiss IKM, Hutten GJ, et al. Caffeine Therapy for Apnea of Prematurity: Single-Center Study on Dosing Practices and Perceived Effectiveness. Neonatology. 2024. doi:10.1159/000543074

BibTeX
@article{Storm2024,
  author = {Storm, Kelly K and Flint, Robert B and Onland, Wes and van Kaam, Anton H and Reiss, Irwin K M and Hutten, G Jeroen and Simons, Sinno H P},
  title = {Caffeine Therapy for Apnea of Prematurity: Single-Center Study on Dosing Practices and Perceived Effectiveness},
  journal = {Neonatology},
  year = {2024},
  doi = {10.1159/000543074}
}
Kostenlos starten →